Labeled Nucleotide Purity via Enzymatic Pre-treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for labeling and purifying nucleotides for nucleic acid analyses result in impure compositions, leading to high background noise and errors in sequencing and hybridization reactions due to the presence of unlabeled nucleotides, which are not fully incorporated by polymerase enzymes.

Innovation Solution

A composition of labeled nucleotides or nucleic acid targets substantially free of unlabeled counterparts is achieved by treating the mixture with agents like phosphatases or exonucleases, rendering unlabeled nucleotides incapable of participating in analytical reactions, thereby ensuring high-resolution detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional labeling and purification methods are used, then the process is simple and cost-effective, but the nucleotide composition contains unlabeled nucleotides leading to high background noise and errors

Engineering Contradiction:
Improvepurity of labeled nucleotide compositionVSAvoidcomplexity of labeling and purification process
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by treating the nucleotide mixture with phosphatase or exonuclease enzymes before the sequencing or hybridization reaction. This pre-treatment selectively degrades unlabeled nucleotides while leaving labeled nucleotides intact, thereby improving purity before the main analytical reaction occurs. The enzyme treatment step is performed in advance to prevent the harmful effects of unlabeled nucleotides during subsequent high-resolution detection.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If polymerase enzymes are used in nucleic acid analyses, then DNA synthesis can occur, but the enzymes prefer natural nucleotides over labeled nucleotide analogs resulting in missed bases

Engineering Contradiction:
Improveefficiency of nucleic acid analysisVSAvoidaccuracy of base detection
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent applies preliminary anti-action by using phosphatase or exonuclease enzymes to selectively remove or modify unlabeled nucleotides before they can interfere with the polymerase reaction. This counter-action occurs in advance to prevent the polymerase from preferentially incorporating unlabeled nucleotides over labeled analogs, thereby eliminating the source of missed bases and improving measurement precision while maintaining productivity.

Inventive Principle:
Principle #9Preliminary anti-action

3Measurement precision

If high-resolution detection methods are used, then accurate detection of labeled nucleotides is achieved, but the presence of unlabeled nucleotides creates high background noise

Engineering Contradiction:
Improveresolution of nucleic acid detectionVSAvoidbackground noise from unlabeled nucleotides
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The patent applies the extraction principle by using phosphatase or exonuclease enzymes to selectively remove unlabeled nucleotides from the mixture before high-resolution detection. This separation step extracts the harmful unlabeled components while retaining the labeled nucleotides, thereby eliminating background noise and enabling accurate high-resolution detection without interference from unlabeled contaminants.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution significantly reduces the presence of unlabeled nucleotides to less than 1%, minimizing errors and background noise in nucleic acid sequencing and hybridization assays, enhancing the accuracy of nucleic acid analyses.

Implementation Method 1

treating the mixture with an agent that selectively renders unlabeled nucleotides or nucleotide analogs substantially incapable of participating in an analytical reaction of interest... The agent can comprise an enzyme. In some embodiments, the enzyme is selected from the group consisting of a phosphatase

Methodology Applied
Scientific EffectPhosphatase enzyme activity: Enzyme

Implementation Method 2

treating the nucleic acid target composition with an agent that selectively renders unlabeled nucleic acid target substantially incapable of participating in a analytical reaction of interest... The agent is an exonuclease enzyme that selectively digests the unlabeled nucleic acid target

Methodology Applied
Scientific EffectExonuclease enzyme activity: Enzyme

Implementation Method 3

a polymerase enzyme and divalent metal ion such as Mg2+ or Mn2+. detecting incorporation of the labeled nucleotide or nucleotide analog by the polymerase, into a nascent nucleic acid strand

Methodology Applied
Scientific EffectDNA polymerization: Enzyme

Data Source

PatentUS8927211B2Nucleotide compositions and uses thereof
Publication Date: 2015.01.06 PACIFIC BIOSCIENCES OF CALIFORNIA INC
  • US8927211B2 patent drawing
  • US8927211B2 patent drawing
  • US8927211B2 patent drawing

AI summary

The present invention relates to preparation of nucleotide compositions and uses thereof for conducting nucleic acid analyzes. The compositions and methods embodied in the present invention are particularly useful for nucleic acid analyzes that require high-resolution detection of labeled nucleotides or labeled nucleic acid targets.